NRx Pharmaceuticals (NRXP) Stock Chart & Stock Price History → The #1 Opportunity of the decade? (From Behind the Markets) (Ad) Free NRXP Stock Alerts $3.04 +0.02 (+0.66%) (As of 04:37 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media NRx Pharmaceuticals Stock Price Performance5 Day Performance-37.70%1 Month Performance-93.37%3 Month Performance-92.49%6 Month Performance-88.81%Year-To-Date Performance-93.07%1 Year Performance-94.98% Receive NRXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsForget NVIDIA, buy this $2 AI stock now…This company is at the center of a trillion-dollar industry, fighting for a piece of a massive $20 billion pentagon contract.Click here to learn more >>> NRXP Stock Chart for Friday, April, 19, 2024 NRXP Chart by TradingView NRx Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2024$4.17$3.02-27.58%$3.24$3.00768,768 shs$28.90 million04/17/2024$4.30$4.17-3.02%$4.30$4.12124,002 shs$39.91 million04/16/2024$4.90$4.30-12.24%$4.75$4.24274,408 shs$41.15 million04/15/2024$5.12$4.90-4.30%$5.20$4.85205,209 shs$46.89 million04/12/2024$5.50$5.12-6.91%$6.00$4.901.12 million shs$49.00 million04/11/2024$5.53$5.50-0.54%$5.60$5.27161,454 shs$52.64 million Get the Latest News and Ratings for NRXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/10/2024$5.16$5.53+7.17%$5.68$4.90173,894 shs$52.92 million04/09/2024$5.48$5.16-5.84%$5.59$4.90157,043 shs$49.38 million04/08/2024$5.30$5.48+3.40%$5.65$5.28325,194 shs$52.44 million04/05/2024$5.20$5.30+1.92%$5.43$5.11143,363 shs$50.72 million04/04/2024$4.74$5.20+9.70%$5.41$4.86263,571 shs$49.76 million04/03/2024$5.00$4.74-5.20%$4.84$4.39164,239 shs$453.62 million04/02/2024$52.50$5.00-90.48%$5.25$4.60163,560 shs$462.15 million04/01/2024$47.19$52.50+11.25%$54.00$46.1817,113 shs$48.53 million03/29/2024$47.19$47.19$54.00$41.5525,756 shs$43.62 million03/28/2024$53.00$47.19-10.96%$54.00$41.5525,304 shs$43.62 million03/27/2024$51.60$53.00+2.71%$55.00$51.003,587 shs$48.99 million03/26/2024$53.00$51.60-2.64%$55.00$51.005,436 shs$47.69 million03/25/2024$56.00$53.00-5.36%$58.00$52.077,648 shs$48.99 million03/22/2024$50.51$56.00+10.87%$60.00$51.0035,370 shs$51.76 million03/21/2024$48.50$50.51+4.14%$52.80$47.0010,335 shs$46.69 million03/20/2024$48.10$48.50+0.83%$49.61$46.006,693 shs$44.83 million03/19/2024$51.50$48.10-6.60%$54.00$47.1610,921 shs$44.46 million03/18/2024$45.51$51.50+13.16%$57.00$46.0019,694 shs$47.60 million03/15/2024$42.60$45.51+6.83%$46.98$41.209,473 shs$42.07 million03/14/2024$46.30$42.60-7.99%$48.59$42.507,479 shs$39.37 million03/13/2024$43.94$46.30+5.37%$49.00$45.0014,830 shs$39.43 million03/12/2024$66.90$43.94-34.32%$57.67$40.5060,327 shs$37.42 million03/11/2024$61.34$66.90+9.06%$72.00$62.0034,779 shs$56.98 million03/08/2024$65.90$61.34-6.92%$64.98$60.0019,679 shs$52.24 million03/07/2024$70.06$65.90-5.94%$70.50$64.7817,387 shs$56.13 million03/06/2024$66.30$70.06+5.67%$73.00$56.5049,308 shs$59.67 million03/05/2024$52.00$66.30+27.50%$73.33$55.00129,744 shs$56.47 million03/04/2024$43.81$52.00+18.69%$54.99$42.5046,407 shs$44.29 million03/01/2024$35.90$43.81+22.03%$44.40$37.0040,146 shs$37.31 million02/29/2024$30.48$35.90+17.78%$36.00$30.5027,341 shs$30.58 million02/28/2024$29.40$30.48+3.67%$31.00$29.2014,161 shs$25.96 million02/27/2024$42.76$29.40-31.24%$30.76$28.0065,996 shs$25.04 million02/26/2024$44.00$42.76-2.82%$47.41$42.516,407 shs$36.42 million02/23/2024$44.00$44.00$47.83$43.136,866 shs$37.48 millionForget NVIDIA, buy this $2 AI stock now… (Ad)This company is at the center of a trillion-dollar industry, fighting for a piece of a massive $20 billion pentagon contract.Click here to learn more >>>02/22/2024$44.63$44.00-1.41%$46.30$43.405,330 shs$37.48 million02/21/2024$44.99$44.63-0.80%$46.86$44.001,651 shs$38.01 million02/20/2024$47.08$44.99-4.44%$49.38$42.2111,447 shs$38.32 million02/19/2024$47.08$47.08$49.00$46.806,590 shs$40.10 million02/16/2024$48.40$47.08-2.73%$49.00$46.806,536 shs$40.10 million02/15/2024$49.21$48.40-1.65%$49.79$47.609,460 shs$41.22 million02/14/2024$49.99$49.21-1.56%$50.00$46.258,609 shs$41.91 million02/13/2024$48.00$49.99+4.15%$50.00$47.004,079 shs$42.58 million02/12/2024$51.20$48.00-6.25%$55.99$46.4527,177 shs$40.88 million02/09/2024$46.40$51.20+10.34%$52.99$48.1022,023 shs$43.61 million02/08/2024$40.63$46.40+14.20%$48.00$39.9016,039 shs$39.52 million02/07/2024$39.33$40.63+3.31%$41.00$38.504,188 shs$34.61 million02/06/2024$39.90$39.33-1.43%$39.90$38.002,179 shs$33.50 million02/05/2024$37.90$39.90+5.28%$40.43$37.504,576 shs$33.98 million02/02/2024$37.39$37.90+1.36%$38.50$37.002,051 shs$32.28 million02/01/2024$37.00$37.39+1.05%$38.98$36.331,409 shs$31.85 million01/31/2024$37.50$37.00-1.33%$39.00$36.003,538 shs$31.51 million01/30/2024$38.40$37.50-2.34%$40.49$36.003,391 shs$31.94 million01/29/2024$38.22$38.40+0.47%$39.92$38.002,043 shs$32.71 million01/26/2024$41.81$38.22-8.59%$41.74$36.017,838 shs$32.55 million01/25/2024$43.90$41.81-4.76%$46.00$37.508,821 shs$35.61 million01/24/2024$42.00$43.90+4.52%$45.00$42.002,541 shs$37.39 million01/23/2024$43.76$42.00-4.02%$47.00$40.825,057 shs$35.77 million01/22/2024$42.48$43.76+3.01%$48.50$43.018,604 shs$37.27 million01/19/2024$42.80$42.48-0.75%$44.00$40.413,389 shs$36.18 million01/18/2024$42.85$42.80-0.12%$43.99$41.011,925 shs$36.45 million Related Companies: Clene Stock Price Chart Eledon Pharmaceuticals Stock Price Chart Marker Therapeutics Stock Price Chart Ocuphire Pharma Stock Price Chart Unicycive Therapeutics Stock Price Chart Cara Therapeutics Stock Price Chart Rockwell Medical Stock Price Chart Bolt Biotherapeutics Stock Price Chart Aadi Bioscience Stock Price Chart ProMIS Neurosciences Stock Price Chart Receive NRXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NRXP) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.